{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T01:16:04Z","timestamp":1748049364183},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.avsg.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T20:20:08Z","timestamp":1716927608000},"page":"152-161","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effectiveness and Safety of Early Versus\u00a0Routine Switching from Low-Molecular-Weight Heparin to Maintenance Therapy of Rivaroxaban for Acute Iliofemoral Vein Thrombosis: A\u00a0Retrospective Cohort Study"],"prefix":"10.1016","volume":"106","author":[{"given":"Wei","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.03.007_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis","volume":"149","author":"Kahn","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.avsg.2024.03.007_bib2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jvs.2007.06.021","article-title":"Iliofemoral venous thrombosis","volume":"46","author":"Comerota","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.03.007_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9343(01)00661-1","article-title":"Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?","volume":"110","author":"James","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.avsg.2024.03.007_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jvir.2022.10.038","article-title":"Society of interventional radiology position statement on the endovascular management of acute iliofemoral deep vein thrombosis","volume":"34","author":"Vedantham","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2024.03.007_bib5","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.03.007_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1503\/cmaj.141614","article-title":"Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline","volume":"187","author":"Liu","year":"2015","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.avsg.2024.03.007_bib8","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.avsg.2024.03.007_bib9","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S2352-3026(19)30209-1","article-title":"Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomized trial","volume":"7","author":"Notten","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.avsg.2024.03.007_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56887-w","article-title":"Rivaroxaban after thrombolysis in acute iliofemoral venous thrombosis: a randomized, open-labeled, multicenter trial","volume":"9","author":"Kang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.avsg.2024.03.007_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2018.10.027","article-title":"Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis","volume":"172","author":"Sebastian","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2024.03.007_bib12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/JCMA.0000000000000206","article-title":"Comparative outcomes of catheter-directed thrombolysis plus rivaroxaban vs rivaroxaban alone in patients with acute iliofemoral deep vein thrombosis","volume":"82","author":"Tsai","year":"2019","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.avsg.2024.03.007_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11239-015-1310-7","article-title":"Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment","volume":"41","author":"Burnett","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.avsg.2024.03.007_bib14","doi-asserted-by":"crossref","first-page":"s255","DOI":"10.1016\/j.jacr.2020.01.035","article-title":"ACR appropriateness Criteria radiologic management of iliofemoral venous thrombosis","volume":"17","author":"K","year":"2020","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.avsg.2024.03.007_bib15","first-page":"1499","article-title":"Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism","volume":"22","author":"Caplin","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2024.03.007_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.suc.2017.11.011","article-title":"Inferior vena cava filters: current indications, techniques, and recommendations","volume":"98","author":"Ha","year":"2018","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.avsg.2024.03.007_bib17","first-page":"651","article-title":"Guidelines for clinical application of vena cava filters","volume":"39","year":"2019","journal-title":"Chin J Practical Hand Surg"},{"key":"10.1016\/j.avsg.2024.03.007_bib18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.06870909","article-title":"Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size","volume":"5","author":"Wm","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.avsg.2024.03.007_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1055\/s-0040-1712913","article-title":"Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: observations on NICE guideline [NG158]","volume":"120","author":"Schulman","year":"2020","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.avsg.2024.03.007_bib20","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jth.12301","article-title":"The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH","volume":"11","author":"Ageno","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.avsg.2024.03.007_bib21","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.avsg.2024.03.007_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.avsg.2024.03.007_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.avsg.2024.03.007_bib24","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","article-title":"Endovascular thrombus removal for acute iliofemoral deep vein thrombosis","volume":"139","author":"Comerota","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.03.007_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.thromres.2013.08.003","article-title":"Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials","volume":"132","author":"Limone","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2024.03.007_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s choice - European society for vascular surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.03.007_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IJGM.S392505","article-title":"Real-world evaluation of the safety and effectiveness of apixaban & rivaroxaban lead-in dosing compared to parenteral lead-in dosing in the treatment of venous thromboembolism: a multi-center retrospective cohort study","volume":"16","author":"Korayem","year":"2023","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.avsg.2024.03.007_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.642907","article-title":"Benefits and harms of low-dose rivaroxaban in asian patients with atrial fibrillation: a systematic review and meta-analysis of real-world studies","volume":"12","author":"Qian","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.avsg.2024.03.007_bib30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chest.2019.04.108","article-title":"Effectiveness and safety of four direct oral anticoagulants in asian patients with nonvalvular atrial fibrillation","volume":"156","author":"Chan","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.avsg.2024.03.007_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2022.09.073","article-title":"Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: a new evidence of Asian dose","volume":"371","author":"Xu","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.avsg.2024.03.007_bib32","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2008-05-160143","article-title":"A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study","volume":"112","author":"Buller","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2024.03.007_bib33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/03007995.2022.2070379","article-title":"Characteristics and clinical outcomes of Japanese patients with venous thromboembolism receiving under-dose rivaroxaban: subanalysis of J\u2019xactly","volume":"38","author":"Fukamachi","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.avsg.2024.03.007_bib34","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism(EINSTEIN DVT)","volume":"363","year":"2010","journal-title":"N Engl J O F Med"},{"key":"10.1016\/j.avsg.2024.03.007_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2017.04.001","article-title":"Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study","volume":"155","author":"Turpie","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2024.03.007_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/jcm12010199","article-title":"Comparative effectiveness of apixaban and rivaroxaban lead-in dosing in VTE treatment: observational multicenter real-world study","volume":"12","author":"Alshaya","year":"2022","journal-title":"J Clin Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050962400222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050962400222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:26:43Z","timestamp":1723177603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089050962400222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"alternative-id":["S089050962400222X"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.03.007","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and Safety of Early Versus\u00a0Routine Switching from Low-Molecular-Weight Heparin to Maintenance Therapy of Rivaroxaban for Acute Iliofemoral Vein Thrombosis: A\u00a0Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}